Atom | Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)

Due Dates: August 1, 2025 (AIDS Renewal/Resubmission/Revision)

Funding Amounts: Up to $350,000/year in direct costs (plus up to $150,000/year for NHP/humanized mouse work if justified); project period up to 4 years

Summary: Supports high-risk, high-impact early discovery research on innovative HIV vaccine approaches, with continued funding contingent on meeting Go/No-Go criteria by Year 2.

Key Information: Go/No-Go milestones required; clinical trials are not allowed; preliminary data are not required.

Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)

Sign in to see full grant listing